"Cure" Versus "Clinical Remission" : The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication
Many people living with HIV (PLWHIV) state that they would be willing to take significant risks to be "cured" of the virus. However, how they interpret the word "cure" in this context is not clear. We used a randomized survey to examine whether PLWHIV had a different willingness to take a hypothetical HIV medication if it causes flu-like symptoms, but provides: (a) cure, (b) remission that was labeled "cure", or (c) remission. PLWHIV (n = 454) were more willing to take a medication that provided a "cure" versus a "remission" if the side effects lasted less than 1 year. PLWHIV were more willing to take a medication that provided a remission that was labeled "cure" versus a "remission" (p = 0.01) if the side effects lasted 2 weeks. Clinicians and researchers should be aware of the impact of the word "cure" and ensure that PLWHIV fully understand the possible outcomes of their treatment options.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
AIDS and behavior - 24(2020), 7 vom: 03. Juli, Seite 2054-2061 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fridman, Ilona [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Behavior |
|---|
| Anmerkungen: |
Date Completed 12.11.2020 Date Revised 02.07.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10461-019-02769-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305003828 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305003828 | ||
| 003 | DE-627 | ||
| 005 | 20231225120219.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10461-019-02769-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1016.xml |
| 035 | |a (DE-627)NLM305003828 | ||
| 035 | |a (NLM)31900813 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fridman, Ilona |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a "Cure" Versus "Clinical Remission" |b The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.11.2020 | ||
| 500 | |a Date Revised 02.07.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Many people living with HIV (PLWHIV) state that they would be willing to take significant risks to be "cured" of the virus. However, how they interpret the word "cure" in this context is not clear. We used a randomized survey to examine whether PLWHIV had a different willingness to take a hypothetical HIV medication if it causes flu-like symptoms, but provides: (a) cure, (b) remission that was labeled "cure", or (c) remission. PLWHIV (n = 454) were more willing to take a medication that provided a "cure" versus a "remission" if the side effects lasted less than 1 year. PLWHIV were more willing to take a medication that provided a remission that was labeled "cure" versus a "remission" (p = 0.01) if the side effects lasted 2 weeks. Clinicians and researchers should be aware of the impact of the word "cure" and ensure that PLWHIV fully understand the possible outcomes of their treatment options | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Behavior | |
| 650 | 4 | |a Cure | |
| 650 | 4 | |a Decision-making | |
| 650 | 4 | |a HIV | |
| 650 | 4 | |a PLWHIV | |
| 650 | 4 | |a Remission | |
| 700 | 1 | |a Ubel, Peter A |e verfasserin |4 aut | |
| 700 | 1 | |a Blumenthal-Barby, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a England, Cameron V |e verfasserin |4 aut | |
| 700 | 1 | |a Currier, Judith S |e verfasserin |4 aut | |
| 700 | 1 | |a Eyal, Nir |e verfasserin |4 aut | |
| 700 | 1 | |a Freedberg, Kenneth A |e verfasserin |4 aut | |
| 700 | 1 | |a Halpern, Scott D |e verfasserin |4 aut | |
| 700 | 1 | |a Kelley, Colleen F |e verfasserin |4 aut | |
| 700 | 1 | |a Kuritzkes, Daniel R |e verfasserin |4 aut | |
| 700 | 1 | |a Le, Catherine N |e verfasserin |4 aut | |
| 700 | 1 | |a Lennox, Jeffrey L |e verfasserin |4 aut | |
| 700 | 1 | |a Pollak, Kathryn I |e verfasserin |4 aut | |
| 700 | 1 | |a Zikmund-Fisher, Brian J |e verfasserin |4 aut | |
| 700 | 1 | |a Scherr, Karen A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t AIDS and behavior |d 1997 |g 24(2020), 7 vom: 03. Juli, Seite 2054-2061 |w (DE-627)NLM09651440X |x 1573-3254 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2020 |g number:7 |g day:03 |g month:07 |g pages:2054-2061 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10461-019-02769-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2020 |e 7 |b 03 |c 07 |h 2054-2061 | ||